西班牙全国铜绿假单胞菌耐药机制与流行病学调查
该调查于2017年从西班牙51家医院收集1445株医疗相关铜绿假单胞菌,检测13种抗铜绿假单胞菌药物的MIC及耐药机制。结果显示黏菌素和头孢他啶/阿维巴坦最敏感(均94.6%),17.3%为XDR,ST175为最常见XDR克隆,碳青霉烯酶产生存在地理差异。
要点
- 黏菌素和头孢他啶/阿维巴坦对临床分离株敏感性最高(94.6%)。
- XDR菌株占17.3%,ST175为最主要高风险克隆(40.9%)。
- 碳青霉烯酶/ESBL检出率3.1%,以VIM、IMP、GES、PER和OXA为主。
核心结论
- ST175是西班牙医院中最常见的XDR高风险克隆。
- 全国范围内流行病学存在复杂的地域差异,包括碳青霉烯酶产生,需据此指导抗菌治疗。
研究设计与样本
- 2017年从51家医院各收集最多30株连续的医疗相关铜绿假单胞菌,共1445株。
- 采用肉汤微量稀释法测定13种抗铜绿假单胞菌药物的MIC,表型方法和PCR检测获得性β-内酰胺酶。
- 通过PFGE和MLST评估克隆流行病学,对每家医院每个克隆至少一株XDR分离株(n=185)进行测序。
主要发现
- 对1445株分离株,黏菌素和头孢他啶/阿维巴坦最敏感(均94.6%敏感,MIC50/90=1/2 mg/L),头孢他啶/阿维巴坦敏感率94.2%(MIC50/90=2/8 mg/L)。
- 252株(17.3%)为XDR,碳青霉烯酶/ESBL检出率3.1%,包括VIM、IMP、GES、PER和OXA酶。
- XDR分离株中最常见克隆为ST175(40.9%),其次为CC235(10.7%)、ST308(5.2%)和CC111(4.0%)。
- 碳青霉烯酶产生存在地理差异,涉及不同克隆,包括16.5%的ST175 XDR分离株。
- 56%的测序XDR分离株携带获得性氨基糖苷修饰酶,与妥布霉素耐药相关;两株XDR产生QnrVC1,但氟喹诺酮耐药主要由QRDR突变引起。
临床怎么用
- 西班牙医院经验性治疗铜绿假单胞菌感染时,应考虑到ST175是最常见的XDR高风险克隆。
- 需认识到碳青霉烯酶产生存在地域差异,以指导抗菌药物选择。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To undertake a Spanish nationwide survey on Pseudomonas aeruginosa molecular epidemiology and antimicrobial resistance. METHODS: Up to 30 consecutive healthcare-associated P. aeruginosa isolates collected in 2017 from each of 51 hospitals were studied. MICs of 13 antipseudomonal agents were determined by broth microdilution. Horizontally acquired β-lactamases were detected by phenotypic methods and PCR. Clonal epidemiology was evaluated through PFGE and MLST; at least one XDR isolate from each clone and hospital (n = 185) was sequenced. RESULTS: The most active antipseudomonals against the 1445 isolates studied were colistin and ceftolozane/tazobactam (both 94.6% susceptible, MIC50/90 = 1/2 mg/L) followed by ceftazidime/avibactam (94.2% susceptible, MIC50/90 = 2/8 mg/L). Up to 252 (17.3%) of the isolates were XDR. Carbapenemases/ESBLs were detected in 3.1% of the isolates, including VIM, IMP, GES, PER and OXA enzymes. The most frequent clone among the XDR isolates was ST175 (40.9%), followed by CC235 (10.7%), ST308 (5.2%) and CC111 (4.0%). Carbapenemase production varied geographically and involved diverse clones, including 16.5% of ST175 XDR isolates. Additionally, 56% of the sequenced XDR isolates showed horizontally acquired aminoglycoside-modifying enzymes, which correlated with tobramycin resistance. Two XDR isolates produced QnrVC1, but fluoroquinolone resistance was mostly caused by QRDR mutations. Beyond frequent mutations (>60%) in OprD and AmpC regulators, four isolates showed AmpC mutations associated with resistance to ceftolozane/tazobactam and ceftazidime/avibactam. CONCLUSIONS: ST175 is the most frequent XDR high-risk clone in Spanish hospitals, but this nationwide survey also indicates a complex scenario in which major differences in local epidemiology, including carbapenemase production, need to be acknowledged in order to guide antimicrobial therapy.
引用
- Del Barrio-Tofiño E, Zamorano L, Cortes-Lara S, et al. Spanish nationwide survey on Pseudomonas aeruginosa antimicrobial resistance mechanisms and epidemiology. J Antimicrob Chemother. 2019. PMID: 30989186. doi:10.1093/jac/dkz147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。